Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Oct 24, 2021 9:00 AM - Oct 26, 2021 6:00 PM

(Tokyo Standard Time)

18th DIA Japan Annual Meeting 2021

DA02: Current and Future Status of Drug Development in Japan, the US, and Europe under COVID-19 Pandemic

Session Chair(s)

E. Stewart  Geary, MD

E. Stewart Geary, MD

Senior Vice President

Eisai Co., Ltd., Japan

Junko  Sato, PhD

Junko Sato, PhD

Associate Executive Director

Pharmaceuticals and Medical Devices Agency (PMDA), Japan


Gerald  Dal Pan, MD, MHS

Gerald Dal Pan, MD, MHS

Director, Office of Surveillance and Epidemiology, CDER

FDA, United States

Peter  Honig, MD, MPH, FACP

Peter Honig, MD, MPH, FACP

Advisor and Board Member, United States

Kiyohito  Nakai, PhD

Kiyohito Nakai, PhD

Director, Pharmaceutical Safty Division

Ministry of Health, Labour and Welfare (MHLW), Japan

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.